Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases

Sarrabeth Stone, Shuangchan Wu, Stephanie Jamison, Wilaiwan Durose, Jean Pierre Pallais, Wensheng Lin

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) play a critical role in immune-mediated demyelinating diseases, including multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE), by regulating the viability of oligodendrocytes. Our previous studies show that activation of the PERK branch of the UPR protects myelinating oligodendrocytes against ER stress in young, developing mice that express IFN-γ, a key pro-inflammatory cytokine in MS and EAE, in the CNS. Several studies also demonstrate that PERK activation preserves oligodendrocyte viability and function, protecting mice against EAE. While evidence suggests activation of the ATF6α branch of the UPR in oligodendrocytes under normal and disease conditions, the effects of ATF6α activation on oligodendrocytes in immune-mediated demyelinating diseases remain unknown. Herein, we showed that ATF6α deficiency had no effect on oligodendrocytes under normal conditions. Interestingly, we showed that ATF6α deficiency exacerbated ER stressed-induced myelinating oligodendrocyte death and subsequent myelin loss in the developing CNS of IFN-γ-expressing mice. Moreover, we found that ATF6α deficiency increased EAE severity and aggravated EAE-induced oligodendrocyte loss and demyelination, without affecting inflammation. Thus, these data suggest the protective effects of ATF6α activation on oligodendrocytes in immune-mediated demyelinating diseases.

Original languageEnglish (US)
Pages (from-to)1331-1345
Number of pages15
JournalGlia
Volume66
Issue number7
DOIs
StatePublished - Jul 2018

Bibliographical note

Funding Information:
We thank Dr. Kazutoshi Mori (Department of Biophysics, Graduate School of Science, Kyoto University, Japan) for providing the ATF6? knock-out mice. We thank Dr. M. A. Aryan Namboodiri (Uniformed Services University of the Health Sciences, Bethesda, MD) for providing the antibody against aspartoacylase. Wensheng Lin is supported by grants from the National Institutes of Health (NS094151 and NS073132) and the National Multiple Sclerosis Society (RG 5239-A-3).

Funding Information:
We thank Dr. Kazutoshi Mori (Department of Biophysics, Graduate School of Science, Kyoto University, Japan) for providing the ATF6α knock-out mice. We thank Dr. M. A. Aryan Namboodiri (Uniformed Services University of the Health Sciences, Bethesda, MD) for providing the antibody against aspartoacylase. Wensheng Lin is supported by grants from the National Institutes of Health (NS094151 and NS073132) and the National Multiple Sclerosis Society (RG 5239-A-3).

Funding Information:
National Institutes of Health, Grant Numbers: NS094151 and NS073132; National Multiple Sclerosis Society, Grant Number: RG 5239-A-3

Publisher Copyright:
© 2018 Wiley Periodicals, Inc.

Keywords

  • ATF6α
  • EAE
  • ER stress
  • IFN-γ
  • multiple sclerosis
  • myelin
  • oligodendrocyte

Fingerprint

Dive into the research topics of 'Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases'. Together they form a unique fingerprint.

Cite this